Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Volz

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
MMW Fortschritte Der Medizin|November 6, 2004
[Somatoform disorders--what must the general practitioner know?]Hans-Peter Volz
Psychiatrische Praxis|September 26, 2003
[Acute schizophreniform disorder in Hashimoto disease]Isabel Teuber, Hans-Peter Volz
Psychiatrische Praxis|September 18, 2003
[Acute Schizophrenic Disorder in a Patient with Hashimoto's Thyroiditis]Isabel Teuber, Hans-Peter Volz
Fortschritte Der Neurologie-Psychiatrie|June 24, 2020
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case reportVerena Sichert, Hans-Peter Volz
Psychiatrische Praxis|September 26, 2003
[Acute paranoid psychotic symptoms after i.m. injection of nandrolone]Isabel Teuber, Daniel Freiwald, Hans-Peter Volz
Acta Neurobiologiae Experimentalis|June 6, 2003
Combined measurement of event-related potentials (ERPs) and fMRIMonika Sommer, Jörg Meinhardt, Hans-Peter Volz
Psychiatrische Praxis|September 18, 2003
[Acute Paranoid Symptoms Following Intramuscular Injection of Nandrolone]Isabel Teuber, Daniel Freiwald, Hans-Peter Volz
Bipolar Disorders|July 24, 2009
Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissueIris C Maurer, Patricia Schippel, Hans-Peter Volz
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilitiesThomas C Baghai, Hans-Peter Volz, Hans-Jürgen Möller
Acta Neuropsychiatrica|March 18, 2016
Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depressionHans-Jürgen Möller, Hans-Peter Volz, Klaus-Dieter Stoll
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
MMW Fortschritte Der Medizin|November 6, 2004
[Somatoform disorders--what must the general practitioner know?]Hans-Peter Volz
Psychiatrische Praxis|September 26, 2003
[Acute schizophreniform disorder in Hashimoto disease]Isabel Teuber, Hans-Peter Volz
Psychiatrische Praxis|September 18, 2003
[Acute Schizophrenic Disorder in a Patient with Hashimoto's Thyroiditis]Isabel Teuber, Hans-Peter Volz
Fortschritte Der Neurologie-Psychiatrie|June 24, 2020
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case reportVerena Sichert, Hans-Peter Volz
Psychiatrische Praxis|September 26, 2003
[Acute paranoid psychotic symptoms after i.m. injection of nandrolone]Isabel Teuber, Daniel Freiwald, Hans-Peter Volz
Acta Neurobiologiae Experimentalis|June 6, 2003
Combined measurement of event-related potentials (ERPs) and fMRIMonika Sommer, Jörg Meinhardt, Hans-Peter Volz
Psychiatrische Praxis|September 18, 2003
[Acute Paranoid Symptoms Following Intramuscular Injection of Nandrolone]Isabel Teuber, Daniel Freiwald, Hans-Peter Volz
Bipolar Disorders|July 24, 2009
Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissueIris C Maurer, Patricia Schippel, Hans-Peter Volz
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilitiesThomas C Baghai, Hans-Peter Volz, Hans-Jürgen Möller
Acta Neuropsychiatrica|March 18, 2016
Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depressionHans-Jürgen Möller, Hans-Peter Volz, Klaus-Dieter Stoll
Pageof 5